Effects of admission serum urea, glomerular filtration rate, proteinuria and diabetes status on 3-month mortality after acute stroke
Iskandar Idris 1,2 , Robert Hill 1 and Jagdish C Sharma 1, 3 from hypovolemia, renovascular disease or reduced cardiac output. Our finding from this study predicting short-term mortality is in contrast to the findings from another study which showed that creatinine was a independent predictor of long-term mortality post-stroke. 4 This large well-conducted study looking at biochemical predictors of longterm outcome after stroke however did not include serum urea as a prognostic determinant. 4 Another study has implicated congestive cardiac failure as a mechanism of raisedurea-induced poor outcome. 5 Interestingly, N-Terminal Brain Natriuretic Peptide level, a sensitive marker of cardiac dysfunction, has also been shown to independently predict short-term mortality post-stroke. 6 It is therefore tempting to speculate the presence of underlying occult heart failure in patients with acute stroke and that interventions with pharmacotherapy to target cardiac disorders may confer short-and longer-term benefits. Our study has also shown that diabetes predicts poor stroke outcome, but it remains unclear whether hyperglycaemia is simply a cause or a marker of poor outcome.
In conclusion, serum urea and diabetes status independently predict short-term mortality following an acute stroke. These parameters should therefore be included in developing future models of quality and prognosis of post-stroke care in predicting short-term mortality.
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Dear Editor,
We have previously shown that elevated serum urea is associated with increased short-term mortality following an ST elevation myocardial infarction 1 . Little is known, however, about its role as a predictor of short-term mortality following an acute stroke. In this study, we analysed the role of serum urea and other biochemical and clinical parameters on 3-month mortality after an acute stroke in a prospective study of patients admitted to a single UK hospital stroke unit. We recruited 125 consecutive patients (mean age 73±12 years), who were able to provide an informed written consent with a low level of pre-admission dependency as assessed on the modified Rankin Scale (mRS < 3). The study was approved by the Nottingham Research Ethics Committee.
Sixteen (13%) patients died by 120 days. Serum urea levels were significantly increased among patients who died compared with those alive at 120 days (10.1±4.6 mmol/l vs. 7.5±4.4 mmol/l, p=0.01). The presence of proteinuria and reduced glomerular filtration rate (GFR) level showed a non-significant increased 120-day mortality (odds ratios [ORs] for 120-day mortality were 2.83 [95% confidence interval (CI) 0.840, 9.228, p=0.083 and 0.97 [95% CI 0.943, 1.004], p=0.092, respectively). No differences were noted for admission systolic blood pressure, Hba1c, glucose, low-density lipoprotein, total cholesterol, serum osmolality, serum creatinine and oxygen saturation levels. The presence of diabetes was associated with increased 120-day mortality compared with non-diabetes (c 2 =1245.6, p=0.001).
The mechanisms underlying the role of increased urea in predicting adverse post-stroke outcomes are unclear. High urea may simply be a surrogate marker of renal dysfunction 2 or concurrent diuretic use in patients with heart failure, 3 two well-recognised predictors of poor clinical outcomes. We have previously shown that the prognostic value of raised serum urea post-myocardial infarction is independent of serum creatinine and other biochemical parameters. 1 In addition to reflecting GFR, an increased serum urea may also reflect a state of renal hypoperfusion
